STATing the obvious: it's time for new treatments in atopic dermatitis.

about

STATing the obvious: it's time for new treatments in atopic dermatitis.

Item

http://www.wikidata.org/entity/Q51744066

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

STATing the obvious: it's time for new treatments in atopic dermatitis.

@en

STATing the obvious: it's time for new treatments in atopic dermatitis.

@nl

type

Item

label

STATing the obvious: it's time for new treatments in atopic dermatitis.

@en

STATing the obvious: it's time for new treatments in atopic dermatitis.

@nl

prefLabel

STATing the obvious: it's time for new treatments in atopic dermatitis.

@en

STATing the obvious: it's time for new treatments in atopic dermatitis.

@nl

P1476

STATing the obvious: it's time for new treatments in atopic dermatitis.

@en

P2093

B A King

http://www.w3.org/2001/XMLSchema#string

W Damsky

http://www.w3.org/2001/XMLSchema#string

P2860

Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

IL-31: a new link between T cells and pruritus in atopic skin inflammation

Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

Prerequisites for Functional Interleukin 31 Signaling and Its Feedback Regulation by Suppressor of Cytokine Signaling 3 (SOCS3).

Effects of the Janus kinase inhibitor CP-690550 (tofacitinib) in a rat model of oxazolone-induced chronic dermatitis.

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.

The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.

P304

861-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJD.15036

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27790697

http://www.w3.org/2001/XMLSchema#string